Ildiko Lingvay

  • 2390 Citations
  • 18 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 33 Similar Profiles
Type 2 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Metformin Medicine & Life Sciences
Medical problems Chemical Compounds
pioglitazone Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Glycosylated Hemoglobin A Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 2390 Citations
  • 18 h-Index
  • 54 Article
  • 4 Review article

Determining insulin dose at the time of discharge in a high-risk population: Is there room for improvement?

Carruthers, D., Ismaily, M., Vanderheiden, A., Yates, M., DeGueme, A., Huet, B. A., Basani, S., Abreu, M. & Lingvay, I., Mar 1 2019, In : Endocrine Practice. 25, 3, p. 263-269 7 p.

Research output: Contribution to journalArticle

Insulin
Population
Prescriptions
Ketosis
Metformin

Efficacy and safety of ideglira in older patients with type 2 diabetes

Lingvay, I., Handelsman, Y., Linjawi, S., Vilsbøll, T., Halladin, N., Ranc, K. & Liebl, A., Feb 1 2019, In : Endocrine Practice. 25, 2, p. 144-155 12 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Safety
Confidence Intervals
Insulin
insulin degludec
4 Citations (Scopus)

A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin

Lingvay, I., Desouza, C. V., Lalic, K. S., Rose, L., Hansen, T., Zacho, J. & Pieber, T. R., Sep 1 2018, In : Diabetes Care. 41, 9, p. 1926-1937 12 p.

Research output: Contribution to journalArticle

Metformin
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Placebos
Exercise
50 Citations (Scopus)

Efficacy and safety of once-Weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-Week, open-Label, randomized clinical trial

Ahmann, A. J., Capehorn, M., Charpentier, G., Dotta, F., Henkel, E., Lingvay, I., Holst, A. G., Annett, M. P. & Aroda, V. R., Feb 1 2018, In : Diabetes Care. 41, 2, p. 258-266 9 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Randomized Controlled Trials
Safety
Hypoglycemic Agents
Body Weight
5 Citations (Scopus)

Hyposialylated IgG activates endothelial IgG receptor FcγRIIB to promote obesity-induced insulin resistance

Tanigaki, K., Sacharidou, A., Peng, J., Chambliss, K. L., Yuhanna, I. S., Ghosh, D., Ahmed, M., Szalai, A. J., Vongpatanasin, W., Mattrey, R. F., Chen, Q., Azadi, P., Lingvay, I., Botto, M., Holland, W. L., Kohler, J. J., Sirsi, S. R., Hoyt, K., Shaul, P. W. & Mineo, C., Jan 2 2018, In : Journal of Clinical Investigation. 128, 1, p. 309-322 14 p.

Research output: Contribution to journalArticle

IgG Receptors
Insulin Resistance
Obesity
Immunoglobulin G
Type 2 Diabetes Mellitus